secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001140361-24-011282
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian leases 20K sq ft cGMP facility in Frederick, MD; director resigns
---------------------------------------------------------------------------

- Leased ~20,000 sq ft manufacturing/office space at 7495 New Horizon Way, Frederick, MD.
- Initial term from April 2024 to May 2031 (7 years) with one 5-year extension option.
- Base rent $902,353/year ($47/sq ft) with 3% annual escalation.
- Director Aymeric Sallin resigned from board effective immediately, not due to disagreement.
- Facility to support cGMP manufacturing for autoimmune disease pipeline; Phase 2b Descartes-08 data due mid-2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000114036124011282/0001140361-24-011282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000114036124011282/ef20023144_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-011282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer